Cherry Lane Theatre Back on the Market After Initial Lortel Sale Falls Through | Playbill

Off-Broadway News Cherry Lane Theatre Back on the Market After Initial Lortel Sale Falls Through
 
The Off-Broadway venue is currently listed at $12.95 million.
The Cherry Lane Theatre
The Cherry Lane Theatre Mary Geerlof

Off-Broadway mainstay Cherry Lane Theatre is back on the market after an initial $11 million sale with the Lucille Lortel Theatre Foundation fell through. Bloomberg reports the complex is currently listed at $12.95 million.

The deal was initially announced in July, with George Forbes set to succeed Angelina Fiordellisi as executive director. No reason was given for why the sale was halted.

Cherry Lane reopened this summer with a return engagement of Jacqueline Novak’s Get On Your Knees. Currently playing at the downtown venue is Neal Brennan’s Unacceptable, with performances scheduled through November 21. Up next is Alex Edelman’s Just For Us, running December 1-19.

See Neil Patrick Harris, Chris Rock, and More Celebrate the Opening of Neal Brennan: Unacceptable Off-Broadway

Click Here to Shop for Theatre
Merchandise in the Playbill Store
 
Industry News
 X

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!